Share

Categories:

EORTC Leukemia Group Virtual Meeting

Virtual Event

PROGRAMME

Thursday 5 November 2020

Time slot

Topic / Title of presentation

Speaker

14:00

Welcome and Introduction M. Lübbert / H. Becker
 

 

14:30

 

Manuscripts and Congress contributions, Varia

  1. sAML Manuscript (Ramadan, Suciu et al.)
  2. Other
  3. SAC Review
 

F. Baron, S. Suciu All
M. Lübbert, H. Becker

 

 

14:45

EORTC-1301-LG (AML-21) status reports:

  1. Clinical data, including response review
  2. TR1: Genetics
  3. TR2: MRD (Flow cytometry)
  4. TR3: DNA methylation
  5. TR MRD: Retrospective data capture
M. Lübbert, G. Huls, P. Wijermans
S. Suciu, M. Kicinski
J. Jansen
A. Venditti
M. Lübbert
M. Lübbert
 

15 :30

 

EORTC-2001-LG (AML-22)

M. Lübbert, F. Baron, A.Venditti , M. Kicinski, Chr. Rummelt

15:50

DECIDER-2 status M. Lübbert

16:10

HR-MDS concept /HMA+ATRA status update M. Lübbert
 

16:20

Other trials
EORTC-65091-06093-IDG-LG: empirical versus pre-emptive
– SPARTA
 

HQ
F. Baron

16:30

HQ report / Next group meeting  

16:45

Summary M. Lübbert / H. Becker

17:00

Adjourn  

PLEASE NOTE: Pre-registration is required and registration is by email invite only.
The login details will be shared with participants shortly before the webinar.

Next events

  • Cancer Medicines Forum workshop

    Amsterdam, NL (Hybrid Event)

  • Spring Roundtable – Encontros da Primavera

    Evora, Portugal

  • EORTC Breast Cancer Group Spring Meeting

    Virtual Event

  • CDDF Workshop on Clinical Research in Central and Eastern Europe

    Karkow (Hybrid)

  • EORTC Imaging Group Spring Meeting

    Brussels, Belgium (hybrid)